PTLF (Petlife Pharmaceuticals) Market Cap: $0.02 Mil (As of Jun. 30, 2026)


What is Petlife Pharmaceuticals Market Cap?

Petlife Pharmaceuticals PTLF Market Cap is $0.02 Mil as of Jun. 30, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Petlife Pharmaceuticals's share price for the quarter that ended in Feb. 2018 was $0.011. Petlife Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Feb. 2018 was 80.26 Mil. Therefore, Petlife Pharmaceuticals's market cap for the quarter that ended in Feb. 2018 was $0.88 Mil.

Petlife Pharmaceuticals's quarterly market cap declined from Aug. 2017 ($9.23 Mil) to Nov. 2017 ($6.66 Mil) and declined from Nov. 2017 ($6.66 Mil) to Feb. 2018 ($0.88 Mil).

Petlife Pharmaceuticals's annual market cap increased from Aug. 2015 ($1.87 Mil) to Aug. 2016 ($6.30 Mil) and increased from Aug. 2016 ($6.30 Mil) to Aug. 2017 ($9.23 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Petlife Pharmaceuticals's Enterprise Value for Today is $0.02 Mil.

Petlife Pharmaceuticals  (OTCPK:PTLF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Petlife Pharmaceuticals Market Cap Related Terms

Petlife Pharmaceuticals Market Cap Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Market Cap Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 68.29 1.87 6.30 9.23

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.63 23.79 9.23 6.66 0.88

PTLF vs PCYN, YBAO, BKIT: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Market Cap falls into.


Petlife Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Petlife Pharmaceuticals's Market Cap for the fiscal year that ended in Aug. 2017 is calculated as

Market Cap (A: Aug. 2017 )=Share Price (A: Aug. 2017 )*Shares Outstanding (EOP) (A: Aug. 2017 )
=$0.125*73.842
=$9.23

Petlife Pharmaceuticals's Market Cap for the quarter that ended in Feb. 2018 is calculated as

Market Cap (Q: Feb. 2018 )=Share Price (Q: Feb. 2018 )*Shares Outstanding (EOP) (Q: Feb. 2018 )
=$0.011*80.257
=$0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.02 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Market Cap of $0.02 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Market Cap too high?
Petlife Pharmaceuticals' current Market Cap is $0.02 Mil. The Drug Manufacturers industry median Market Cap is 213.67. Petlife Pharmaceuticals' value of $0.02 Mil is 100% below this industry median.
How does Petlife Pharmaceuticals' Market Cap compare to PCYN and YBAO?
Petlife Pharmaceuticals' Market Cap of $0.02 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 213.67. Petlife Pharmaceuticals' value of $0.02 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Petlife Pharmaceuticals's current Market Cap of $0.02 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Petlife Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Petlife Pharmaceuticals's current Market Cap is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Market Cap of $0.02 Mil. The current Market Cap is $0.02 Mil and 100% below the Drug Manufacturers industry median of 213.67. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Market Cap is $0.02 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.